Motor Neurone Disease Association (MND): Longitude Prize on ALS – Stage 1: Discover

International programme that seeks to incentivise the use of AI-based approaches to transform therapeutic discovery for the treatment of amyotrophic lateral sclerosis (ALS), the most common form of motor neurone disease (MND).
Funding: £100K for 9 months (20 teams)
Next stages (total 5 years for all stages):
Stage 2: Prioritize – £200K for 12 months (10 teams), Stage 3: Validate – £500K for 24 months (5 teams), Winner Award – £1M.
https://als.longitudeprize.org/